SACRAMENTO, California – July 24, 2018
S&W Seed Company (Nasdaq: SANW) today announced that it has expanded its existing agreement with an international consumer products company to perform breeding and targeting of novel stevia traits. The objective of the collaboration is the improvement of stevia varieties.
Mark Wong, President and Chief Executive Officer of S&W Seed Company, commented, “We are excited to expand this agreement to develop specific stevia germplasm lines that have the potential to be utilized in numerous products around the world. S&W’s expertise in stevia research and development, and understanding of U.S.-based production dynamics, has brought us to this exciting opportunity. Ultimately, the goal of the collaboration is the proliferation of stevia acres globally, which we anticipate will provide tremendous opportunities for S&W and our partners in our pursuit to support healthier consumer diets.”
About S&W Seed Company
Founded in 1980, S&W Seed Company is a global agricultural company headquartered in Sacramento, California. S&W’s vision is to be the world’s preferred proprietary seed company which supplies a range of forage and specialty crop products that supports the growing global demand for animal proteins and healthier consumer diets. S&W is a global leader in alfalfa seed, with significant research and development, production and distribution capabilities. S&W’s capabilities span the world’s alfalfa seed production regions, with operations in the Western United States, including the San Joaquin and Imperial Valleys of California, Australia, and Canada, and S&W sells its seed products in more than 30 countries around the globe. S&W also provides hybrid sorghum and sunflower and is utilizing its research and breeding expertise to develop and produce stevia, the all-natural, zero calorie sweetener for the food and beverage industry. For more information, please visit www.swseedco.com.
Safe Harbor Statement
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may,” “future,” “plan” or “planned,” “will” or “should,” “expected,” “anticipates,” “draft,” “eventually” or “projected.” Forward-looking statements in this release include, but are not limited to, statements concerning the potential utilization of our stevia germplasm lines in numerous products around the world, the anticipated benefits of proliferation of stevia acres globally, including the potential resulting opportunities to support healthier diets with our partners, and our ability to execute on our stevia production and commercialization strategies. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risk that our strategic initiatives may not achieve the expected results, and risks associated with our ability to successfully optimize and commercialize our business . These and other risks are identified in our filings with the Securities and Exchange Commission, including without limitation our Annual Report on Form 10-K for the fiscal year ended June 30, 2017, and in our other filings subsequently made with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.